A Study to Evaluate the Safety of Lactobacillus Salivarius AP-32 and Bifidobacterium Lactis CP-9 in Healthy Infants.

clinical trial

Wikidata entity: Q74272674



Quantities

P1132number of participants216

P17 country ... Q865 (Taiwan) Taiwan
P582 end time ... 2020-02-24 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P921 main subject ... Q3825336 (Ligilactobacillus salivarius) Ligilactobacillus salivarius
P921 main subject ... Q62854400 (Bifidobacterium lactis) Bifidobacterium lactis
P580 start time ... 2019-10-28 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext A Three-arm, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of Lactobacillus Salivarius AP-32 and Bifidobacterium Lactis CP-9 Used Individually in Healthy Infants ???

External Ids
P3098ClinicalTrials.gov IDNCT04140604

Why not click here or view trends?

log id: 4737013